Phase I study of combination chemotherapy consisting of capecitabine plus fractional cisplatin for unresectable gastric cancer in an outpatient setting. Efficacy and safety of regorafenib in Korean ...

(HealthDay News) — For acute myocardial infarction (AMI) survivors, angiotensin-converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) treatment is associated with improved ...

The side effects of ACEIs and ARBs may be resulting in less frequent use in a population that could benefit from these medications. A new study found that continuous ACEI/ARB use prior to dialysis ...

—Patients taking commonly used chemotherapies for non–small-cell lung cancer have longer survival if they also receive a angiotensin system inhibitor. Why? Share on Facebook. Opens in a new tab or ...